國立高雄大學圖資館 |

Language: English

Back

The marathon of the messengera history of messenger RNA vaccines /

Record Type:	Electronic resources : Monograph/item
Title/Author:	The marathon of the messengerby Jerome Lemonnier, Nicolas Lemonnier ; drawings by Gilles Charrot ; foreword by Pierre Meulien.
Reminder of title:	a history of messenger RNA vaccines /
Author:	Lemonnier, Jerome.
other author:	Lemonnier, Nicolas.
Published:	Cham :Springer International Publishing :2023.
Description:	xxiii, 202 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	mRNA vaccinesHistory.
Online resource:	https://doi.org/10.1007/978-3-031-39300-6
ISBN:	9783031393006$q(electronic bk.)

The marathon of the messengera history of messenger RNA vaccines /
Lemonnier, Jerome.

The marathon of the messengera history of messenger RNA vaccines /[electronic resource] :by Jerome Lemonnier, Nicolas Lemonnier ; drawings by Gilles Charrot ; foreword by Pierre Meulien. - Cham :Springer International Publishing :2023. - xxiii, 202 p. :ill., digital ;24 cm.

Chapter 1. Introduction: The Marathon of the Messenger RNA -- Part I. Messenger RNA, an essential role and challenge -- Chapter 2. A short history of vaccination -- Chapter 3. From DNA to RNA -- Chapter 4. Messenger RNA (mRNA): from transcription to protein translation -- Chapter 5. The mechanism of viral infection -- Chapter 6. The immune response -- Part II. From preliminary studies to clinical trials -- Chapter 7. Promising studies in the 1990s -- Chapter 8. The use of mRNA - the initial technical obstacles -- Chapter 9. The birth of CureVac: the era of the pioneers -- Chapter 10. Solutions for mRNA optimization -- Chapter 11. Modified and unmodified mRNA: for what purpose? -- Chapter 12. Experiments and clinical trials conducted: the power of therapeutic mRNA -- Chapter 13. Experiments and clinical trials against infectious diseases -- Chapter 14. Experiments and clinical trials against cancer -- Chapter 15. Experiments and clinical trials carried out in other therapeutic fields -- Chapter 16. Modified mRNA versus unmodified mRNA: not just a scientific issue -- Part III. The triumph of messenger RNA -- Chapter 17. A very progressive diffusion in scientific circles -- Chapter 18. The development of future biotechs in the 2010s -- Chapter 19. The importance of intellectual property and patents -- Chapter 20. 2020: the triumph of anti-Covid mRNA vaccines -- Chapter 21. mRNA, a technology of the future.

The Covid-19 pandemic changed the world. Indeed a real race took place worldwide between SARS-CoV-2 on the one hand and researchers on the other - especially those specializing in messenger RNA vaccines. Four years after its emergence, the pandemic is not over, but some decisive battles have been won, thanks to the great success of mRNA vaccines. The Marathon of The Messenger presents the history of these mRNA vaccines, combining a scientific background with historical and economic perspectives. It appears that an important page in the history of these new vaccines was written in Europe, thanks to the crucial work of German and French scientists; this effort began in 1993 and continues to this day. In the face of a prevailing single-mindedness, these researchers pushed through a new therapeutic concept and defined the biotechnological keys that would open the way to the production of therapeutic messenger RNA in the fight against cancer and viral infections. Written for a broad audience and accompanied by humorous cartoons, this book will appeal to anyone looking for scientific and historical answers about mRNA vaccines. Readers will discover not only the technical and scientific knowledge of how these vaccines work, but also the economic levers that were necessary to create this technology. This book has been written in collaboration with Dr. Steve Pascolo, former director of CureVac, and the RNA messenger expert Professor Chantal Pichon. It also features a preface by Dr. Pierre Meulien, former director of the European Union public-private partnership Innovative Medicines Initiative (IMI) This book is a translation of an original French edition. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com) A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation.

ISBN: 9783031393006$q(electronic bk.)

Standard No.: 10.1007/978-3-031-39300-6doiSubjects--Topical Terms:

962163
mRNA vaccines
--History.

LC Class. No.: QR189.2

Dewey Class. No.: 615.19

The marathon of the messengera history of messenger RNA vaccines /
LDR:04438nmm a2200325 a 4500 001 651789
003 DE-He213
005 20231101111904.0
006 m d
007 cr nn 008maaau
008 240327s2023 sz s 0 eng d
020 $a 9783031393006$q(electronic bk.)
020 $a 9783031392993$q(paper)
024 7 $a 10.1007/978-3-031-39300-6 $2 doi
035 $a 978-3-031-39300-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR189.2
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
072 7 $a MJCM $2 thema
082 0 4 $a 615.19 $2 23
090 $a QR189.2 $b .L557 2023
100 1 $a Lemonnier, Jerome. $3 962159
245 1 4 $a The marathon of the messenger $h [electronic resource] : $b a history of messenger RNA vaccines / $c by Jerome Lemonnier, Nicolas Lemonnier ; drawings by Gilles Charrot ; foreword by Pierre Meulien.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xxiii, 202 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Introduction: The Marathon of the Messenger RNA -- Part I. Messenger RNA, an essential role and challenge -- Chapter 2. A short history of vaccination -- Chapter 3. From DNA to RNA -- Chapter 4. Messenger RNA (mRNA): from transcription to protein translation -- Chapter 5. The mechanism of viral infection -- Chapter 6. The immune response -- Part II. From preliminary studies to clinical trials -- Chapter 7. Promising studies in the 1990s -- Chapter 8. The use of mRNA - the initial technical obstacles -- Chapter 9. The birth of CureVac: the era of the pioneers -- Chapter 10. Solutions for mRNA optimization -- Chapter 11. Modified and unmodified mRNA: for what purpose? -- Chapter 12. Experiments and clinical trials conducted: the power of therapeutic mRNA -- Chapter 13. Experiments and clinical trials against infectious diseases -- Chapter 14. Experiments and clinical trials against cancer -- Chapter 15. Experiments and clinical trials carried out in other therapeutic fields -- Chapter 16. Modified mRNA versus unmodified mRNA: not just a scientific issue -- Part III. The triumph of messenger RNA -- Chapter 17. A very progressive diffusion in scientific circles -- Chapter 18. The development of future biotechs in the 2010s -- Chapter 19. The importance of intellectual property and patents -- Chapter 20. 2020: the triumph of anti-Covid mRNA vaccines -- Chapter 21. mRNA, a technology of the future.
520 $a The Covid-19 pandemic changed the world. Indeed a real race took place worldwide between SARS-CoV-2 on the one hand and researchers on the other - especially those specializing in messenger RNA vaccines. Four years after its emergence, the pandemic is not over, but some decisive battles have been won, thanks to the great success of mRNA vaccines. The Marathon of The Messenger presents the history of these mRNA vaccines, combining a scientific background with historical and economic perspectives. It appears that an important page in the history of these new vaccines was written in Europe, thanks to the crucial work of German and French scientists; this effort began in 1993 and continues to this day. In the face of a prevailing single-mindedness, these researchers pushed through a new therapeutic concept and defined the biotechnological keys that would open the way to the production of therapeutic messenger RNA in the fight against cancer and viral infections. Written for a broad audience and accompanied by humorous cartoons, this book will appeal to anyone looking for scientific and historical answers about mRNA vaccines. Readers will discover not only the technical and scientific knowledge of how these vaccines work, but also the economic levers that were necessary to create this technology. This book has been written in collaboration with Dr. Steve Pascolo, former director of CureVac, and the RNA messenger expert Professor Chantal Pichon. It also features a preface by Dr. Pierre Meulien, former director of the European Union public-private partnership Innovative Medicines Initiative (IMI) This book is a translation of an original French edition. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com) A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation.
650 0 $a mRNA vaccines $x History. $3 962163
650 1 4 $a Immunology. $3 189152
650 2 4 $a Biological Techniques. $3 276128
650 2 4 $a Biotechnology. $3 188829
650 2 4 $a Molecular Biology. $3 189026
650 2 4 $a Industrial and Production Engineering. $3 273753
700 1 $a Lemonnier, Nicolas. $3 962160
700 1 $a Charrot, Gilles. $3 962161
700 1 $a Meulien Pierre. $3 962162
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-39300-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)